AT359300T
Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
Abstract
The present invention offers refining Flt4 receptor type tyrosine kinase polypeptide and its fragment, the polynucleotide that carries out the code of such polypeptides, the probes specifically combined with such polypeptides, and those use.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
153 members in 17 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 76553401 | United States of America | A |
Members153
| Document | Office | Kind | |
|---|---|---|---|
| CA2192235A1 | Canada | A1 | |
| WO9533772A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2738895A | Australia | A | |
| NO965231D0 | Norway | D0 | |
| NO965231L | Norway | L | |
| FI964862A | Finland | A | |
| CA2228248A1 | Canada | A1 | |
| WO9705250A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6616996A | Australia | A | |
| WO9705250A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0807124A1 | European Patent Office (EPO) | A1 | |
| JPH10500858A | Japan | A | |
| MX9606218A | Mexico | A | |
| EP0842273A2 | European Patent Office (EPO) | A2 | |
| US5776755A | United States of America | A | |
| AU694524B2 | Australia | B2 | |
| CA2279554A1 | Canada | A1 | |
| WO9833917A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6262498A | Australia | A | |
| NZ288235A | New Zealand | A | |
| WO9833917A9 | World Intellectual Property Organization (WIPO) | A9 | |
| JPH11510689A | Japan | A | |
| HK1014984A1 | Hong Kong, China | A1 | |
| AU711578B2 | Australia | B2 | |
| EP0972028A1 | European Patent Office (EPO) | A1 | |
| CA2345276A1 | Canada | A1 | |
| WO0021560A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1312100A | Australia | A | |
| US6107046A | United States of America | A | |
| WO0021560A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US6130071A | United States of America | A | |
| NO20011759D0 | Norway | D0 | |
| US6221839B1 | United States of America | B1 | |
| NO20011759L | Norway | L | |
| US6245530B1 | United States of America | B1 | |
| NZ313647A | New Zealand | A | |
| EP1119371A1 | European Patent Office (EPO) | A1 | |
| JP2001523951A | Japan | A | |
| CN1329504A | China | A | |
| US6361946B1 | United States of America | B1 | |
| AU748369B2 | Australia | B2 | |
| US6403088B1 | United States of America | B1 | |
| CA2435503A1 | Canada | A1 | |
| WO02060950A2 | World Intellectual Property Organization (WIPO) | A2 | |
| JP2002527404A | Japan | A | |
| WO02060950A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU748369C | Australia | C | |
| US2003091567A1 | United States of America | A1 | |
| NO20033285D0 | Norway | D0 | |
| NO20033285L | Norway | L | |
| EP1353952A2 | European Patent Office (EPO) | A2 | |
| US6645933B1 | United States of America | B1 | |
| WO02060950B1 | World Intellectual Property Organization (WIPO) | B1 | |
| US2004037820A1 | United States of America | A1 | |
| NZ511408A | New Zealand | A | |
| US6730658B1 | United States of America | B1 | |
| CN1494552A | China | A | |
| AU774266B2 | Australia | B2 | |
| US2004147448A1 | United States of America | A1 | |
| US2004147726A1 | United States of America | A1 | |
| AU2004208675A1 | Australia | A1 | |
| JP2004532004A | Japan | A | |
| US2004208879A1 | United States of America | A1 | |
| US6818220B1 | United States of America | B1 | |
| US6824777B1 | United States of America | B1 | |
| EP0842273B1 | European Patent Office (EPO) | B1 | |
| AT290594T | Austria | T | |
| ATE290594T1 | Austria | T1 | |
| DE69634437D1 | Germany | D1 | |
| JP2005139199A | Japan | A | |
| DK0842273T3 | Denmark | T3 | |
| NO319383B1 | Norway | B1 | |
| NZ529063A | New Zealand | A | |
| PT842273E | Portugal | E | |
| ES2238694T3 | Spain | T3 | |
| JP3723210B2 | Japan | B2 | |
| EP1612268A1 | European Patent Office (EPO) | A1 | |
| AU2004208675B2 | Australia | B2 | |
| AU2002300880B2 | Australia | B2 | |
| DE69634437T2 | Germany | T2 | |
| US7034105B2 | United States of America | B2 | |
| EP0807124B1 | European Patent Office (EPO) | B1 | |
| AT326484T | Austria | T | |
| ATE326484T1 | Austria | T1 | |
| DE69534996D1 | Germany | D1 | |
| US2006177901A1 | United States of America | A1 | |
| DK0807124T3 | Denmark | T3 | |
| PT807124E | Portugal | E | |
| US7125714B2 | United States of America | B2 | |
| AU2002300880C1 | Australia | C1 | |
| ES2263152T3 | Spain | T3 | |
| EP1353952B1 | European Patent Office (EPO) | B1 | |
| DE69534996T2 | Germany | T2 | |
| AT359300TThis record | Austria | T | |
| ATE359300T1 | Austria | T1 | |
| DE60219419D1 | Germany | D1 | |
| DE60219419T2 | Germany | T2 | |
| AU2002248372B2 | Australia | B2 | |
| CN100340291C | China | C | |
| AU2002248372B8 | Australia | B8 |
Showing 100 of 153
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2717361
Titles2
- German
- FLT4 (VEGFR-3) ALS EIN ZIEL FÜR KREBS DARSTELLUNG UND ANTI-KREBS-BEHANDLUNG
- English
- FLT4 (VEGFR-3) AS A GOAL FOR CANCER PRESENTATION AND ANTI-CANCER TREATMENT
Classification
- CPC, 23
- C07K16/2863
- A61K9/00
- A61K38/00
- A61K48/00
- A61K2039/505
- A61P15/00
- A61P35/00
- A61P35/02
- A61P35/04
- A61P43/00
- C07H21/00
- C07K14/71
- C07K2317/21
- C07K2317/24
- C07K2317/76
- C07K2319/00
- C07K2319/30
- C12N9/12
- C12N9/1205
- C12N15/62
- C12N15/63
- C12Y207/10001
- A61K39/00
- IPC, 32
- A61K31 7088
- A61K31 713
- A61K35 76
- A61K38 00
- A61K38 17
- A61K38 18
- A61K39 00
- A61K45 00
- A61K47 48
- A61K48 00
- A61K9 00
- A61K9 48
- A61P15 00
- A61P35 00
- A61P43 00
- C07K
- C07K14 705
- C07K14 71
- C07K16 28
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 12
- C12N15 18
- C12N15 62
- C12N5 10
- C12N9 12
- C12Q1 02
- C12Q1 68
- G01N33 574